chr2-47403329-C-G
Variant summary
The NM_000251.3(MSH2):c.138C>G (p.His46Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000441 (AC=709) in the gnomAD database across 1,606,276 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000539. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.H46D: Uncertain_significance (ClinVar VariationId 1058599, 1 star); p.H46= (synonymous): Benign/Likely_benign (ClinVar VariationId 491770, 2 stars); p.H46P: Uncertain_significance (ClinVar VariationId 525765, 2 stars); p.H46Q: Benign (ClinVar VariationId 3772757, 1 star); p.H46Y: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 483663) This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000251.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Muir-Torre syndromeInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_benign. The variant received -6 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| BP6Reputable source reports benign | ClinVar ≥3 stars benign — very strong (BP6); ClinVar submissions overwhelmingly benign (≥10 total, ≥80% B/LB, <10% P/LP) — strong (BP6, count-based); ClinVar germline classification: Benign/Likely Benign, 3 star(s). ClinVar submissions strongly and reliably favor benignity (20/24 total B/LB). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | MANE Select | c.138C>G p.His46Gln | missense | Exon 1 of 16 | Prot: NP_000242.1 UniProt: | |
MSH2 | c.138C>G p.His46Gln | missense | Exon 1 of 18 | Prot: NP_001393603.1 | ||
MSH2 | c.138C>G p.His46Gln | missense | Exon 1 of 18 | Prot: NP_001393560.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH2 | TSL:1MANE Select | c.138C>G p.His46Gln | missense | Exon 1 of 16 | Prot: ENSP00000233146.2 UniProt: | |
MSH2 | TSL:1 | c.138C>G p.His46Gln | missense | Exon 1 of 16 | Prot: ENSP00000384199.1 UniProt: | |
MSH2 | c.138C>G p.His46Gln | missense | Exon 1 of 17 | Prot: ENSP00000588166.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000217 | AC:33 | Hom:0 | AN:152252 | Cov:33 |
GnomAD2 exomes | AF: 0.000218 | AC:50 | AN:229550 | ||
GnomAD4 exome | AF: 0.000465 | AC:676 | Hom:0 | AN:1454024 | Cov:31 |
GnomAD4 genome | AF: 0.000217 | AC:33 | Hom:0 | AN:152252 | Cov:33 |
TOPMed (Bravo) | AF: 0.000257 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.000272 | AC:13 | Hom:0 | AN:47750 | |
Local & regional cohorts 4 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.000854 | AC:2 | Hom:0 | AN:2342 | |
ESP6500 (Exome Variant Server) | AF: 0.000231 | AC:3 | AN:12966 | ||
GenomeAsia100K | AF: 0.000289 | AC:1 | AN:3478 | ||
UK10K | AF: 0.000264 | AC:2 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.000522 * | 5 | 9584 | 0.000385 * | 4 | 10388 |
BipEx | 0.000387 | 11 | 28420 | 0.000243 | 7 | 28844 |
Epi25 | 0.000381 | 16 | 41958 | 0.000478 | 32 | 66888 |
SCHEMA | 0.000165 | 20 | 120994 | 0.000244 | 46 | 188366 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.97 | |
BayesDel_addAF | Pathogenic | 0.23 | D |
BayesDel_noAF | Pathogenic | 0.42 | |
CADD | Uncertain | 25 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Pathogenic | 0.88 | D |
Eigen | Uncertain | 0.63 | |
Eigen_PC | Uncertain | 0.53 | |
FATHMM_MKL | Uncertain | 0.94 | D |
FuncVEP CTI | Pathogenic | 0.98 | |
GPN-Star LLR | N/A | -8.6 | |
GPN-Star score | N/A | 8.6 | |
LIST_S2 | Benign | 0.85 | T |
M_CAP | Pathogenic | 0.70 | D |
MetaRNN | Pathogenic | 0.90 | D |
MetaSVM | Pathogenic | 0.89 | D |
Mutation Taster | N/A | 93/7 | polymorphism |
MutationAssessor | Pathogenic | 3.6 | H |
PhyloP100 | Benign | 2.3 | |
popEVE | Benign | -3.6 | |
PrimateAI | Uncertain | 0.78 | T |
PromoterAI | N/A | 0.038 | Neutral |
PROVEAN | Pathogenic | -6.7 | D |
REVEL | Pathogenic | 0.89 | |
Sift | Uncertain | 0.0020 | D |
Sift4G | Uncertain | 0.0020 | D |
Varity_R | N/A | 0.98 | |
VESM-3B | Benign | -9.6 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- MSH2
- Assay type
- Cell fitness
- Mechanism
- DNA and Mismatch repair
- Model system
- Immortalized human cells (Homo sapiens)
- Score
- -3.65 · p.His46Gln (assay numbering)